2021
DOI: 10.1111/ijd.15777
|View full text |Cite
|
Sign up to set email alerts
|

New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
69
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 64 publications
(71 citation statements)
references
References 5 publications
2
69
0
Order By: Relevance
“…Previous reported cases of post COVID‐19 vaccine associated reactivated or new onset LCV or IgA vasculitis were seen with either mRNA or inactivated SARS‐CoV‐2 vaccines but none with recombinant corona virus vaccine (Table S1 ). 4 , 7 , 8 , 9 , 10 , 11 In both of our cases, a temporal association between vaccination and LCV could be established with a probable causal relationship in case 1 and definite relationship in case 2. Historically, first LCV episode in case 2 occurred 7 days after vaccination, which was mild with rash limited to ankles, resolving within a week and without any constitutional symptoms.…”
Section: Discussionsupporting
confidence: 52%
“…Previous reported cases of post COVID‐19 vaccine associated reactivated or new onset LCV or IgA vasculitis were seen with either mRNA or inactivated SARS‐CoV‐2 vaccines but none with recombinant corona virus vaccine (Table S1 ). 4 , 7 , 8 , 9 , 10 , 11 In both of our cases, a temporal association between vaccination and LCV could be established with a probable causal relationship in case 1 and definite relationship in case 2. Historically, first LCV episode in case 2 occurred 7 days after vaccination, which was mild with rash limited to ankles, resolving within a week and without any constitutional symptoms.…”
Section: Discussionsupporting
confidence: 52%
“… 3 To our knowledge, there has been only one case of IgA vasculitis following COVID‐19 vaccination. 4 In this case, there was a history of COVID‐19 and IgA vasculitis developed after the first dose of COVID‐19 vaccine. It was speculated that IgA antibodies against SARS‐CoV‐2 enhanced the development of cutaneous purpuric dermatitis with immune complex deposition after COVID‐19 vaccination.…”
Section: Figurementioning
confidence: 84%
“…3 To our knowledge, there has been only one case of IgA vasculitis following COVID-19 vaccination. 4 In this case,…”
Section: Case Of Immunoglobulin a Vasculitis Following Coronavirus Disease 2019 Vaccinationmentioning
confidence: 93%
“…Vasculitis after COVID-19 vaccination has been reported in different dermatological areas [ 5 , 6 ]. A recent study demonstrated that the frequencies of vasculitis within approximately two weeks after the first dose of Pfizer (New York, NY, USA)-BioNTech (Mainz, Germany) (BNT162b2) and Moderna (mRNA-1273) vaccine were 2.9% and 0.7%, respectively [ 8 ].…”
Section: Discussionmentioning
confidence: 99%